REFLAB is a system being built to kill the most thankless job in pharma communication: numbering, checking, and renumbering references. We're not launching it to the world yet. First we're assembling the 20 people who hate this more than anyone alive.
Prove you're a Ref Hater →60 seconds. No pitch. Just tell us how much you hate it.
You squint at two citations that look 95% identical. Same authors, almost the same year, one typo away from being the same source. Or one typo away from a compliance miss. So you check. Then you re-check. Then you go hunting for where it first appeared, so you reuse the right number instead of inventing a new one. Again.
A 30-page visual aid. Someone moves a paragraph on page 4. Now references 12 through 30 are off. You renumber the whole piece by hand and pray you didn't miss one. You did. You'll find it Friday at 7pm.
This work never touches a creative idea, never moves a campaign, never helps a single patient. It's mandatory bureaucracy you can't escape, and somehow it lands on your desk every time.
If you read all three nodding, you're qualified.
We're holding back the feature list on purpose, because there's no final product to show you yet. It's being created as you read this to fight a shared enemy: a manual, ambiguous, soul-flattening process that every regulated market on Earth forces onto comms work, and that nobody has ever bothered to fix. We're bothering.
1 Still references without the drama. We're consistent like that.
This is a founding seat in the company that ends referencing pain, built alongside the people who hate it most. Read what the seat actually holds.
Membership closes at twenty. Once the seats are taken, the door doesn't open again. There's no second tier.
The 20 of you decide what “fixed” means and watch the system get built around your answers.
Approved founders hold a percentage of REFLAB's profit for two decades. Your hatred becomes equity.
We launch globally only when all 20 of you have one thing: the quiet of knowing this job is finally fast, reliable, and behind you.
Anyone can leave an email. Founding Ref Haters earn the seat by answering one question, and your answer is how we choose.
If your pain is real, we'll know. Watch your inbox.
The founding club is for the 20 angriest people alive. If that's not you, but you still want REFLAB the day it opens, leave your details and we'll keep you first in line. No hatred required.
We'll only reach out when there's something real to show you.
Real. REFLAB is being built right now. The 20 founders genuinely co-create the system and genuinely hold a profit share. The exclusivity runs the whole model.
You give us honesty and your time shaping the product. We give you founder status and a share of what we build together. That's the trade.
Approved founders receive a defined percentage of company profit for 20 years, formalized in writing before you commit to anything. No surprises, no fine print games.
REFLAB exists because of compliance. The whole point is to make referencing more reliable. You'll have full visibility into how it handles citations, audit trails, and version changes.
Any market where local law requires references in claims and content. The system is built market-agnostic from day one.
Both belong here. Agencies running pharma accounts feel the same pain as the medical-review and marketing people client-side. Both can apply.
The world gets REFLAB when the 20 angriest people in pharma comms finally find peace. Be one of them.
Prove you're a Ref Hater →